natgillin/translations-raw huggingface dataset:
Its secondary pharmacological effects are respiratory depression, bradycardia, hypothermia, constipation, miosis, physical dependence and euphoria (see section 5.2). 
Sekundarni farmakološki učinki so depresija dihanja, bradikardija, hipotermija, zaprtost, mioza, telesna odvisnost in evforija (glejte poglavje 5.2).
Patients were enrolled shortly after major surgery if they were not opioid tolerant, were expected to have an uncomplicated recovery, and required at least 24 hours of parenteral opioid treatment. 
Bolniki so začeli sodelovati v študiji kmalu po večji operaciji, če niso imeli tolerance na opioide, če je bilo pričakovano nezapleteno okrevanje in če so potrebovali vsaj 24-urno parenteralno zdravljenje z opioidi.
Before any surgery, the healthcare professional should ensure that the patient has been properly informed on how to use IONSYS post-operatively. 
Pred vsakim kirurškim posegom mora zdravstveni delavec poskrbeti, da je bolnik ustrezno obveščen o tem, kako mora uporabljati sistem IONSYS po operaciji.
None of the four demographic factors studied [weight (lean/obese), age, race, or gender] had a significant effect on active substance exposure (AUC) following use of IONSYS. 
Noben od štirih preučevanih demografskih dejavnikov [telesna masa (majhna/čezmerna), starost, rasa ali spol] ni imel pomembnega vpliva na izpostavljenost zdravilu (AUC) po uporabi sistema IONSYS.
Each time you are given a new IONSYS you may find you initially need to have more doses to relieve your pain than later on during treatment. 
Vsakič, ko dobite nov sistem IONSYS, boste morda ugotovili, da na začetku potrebujete za lajšanje bolečin več odmerkov kot pozneje med zdravljenjem.
Opioids may obscure the clinical course of patients with head injury. 
Opioidi lahko prikrijejo klinični potek pri bolnikih s poškodbami glave.
- Do not take it off or attempt to put it back on yourself. 
- Sami sistema ne odstranite in ne poskusite ga znova namestiti.
The main binding protein is alpha-1-acid glycoprotein, but both albumin and lipoproteins contribute to some extent. 
Glavna vezna beljakovina je alfa-1-kisli glikoprotein, do neke mere pa tudi albumin in lipoproteini.
In general, the maximum serum fentanyl concentration occurs approximately 15 minutes after the initiation of a dose. 
V splošnem je serumska koncentracija fentanila najvišja približno 15 minut po začetku dovajanja odmerka.
Patients could remain in their respective study up to 72 hours if they required parenteral opioid analgesia for this duration. 
Bolniki so lahko ostali v študiji do 72 ur, če so toliko časa potrebovali parenteralno opioidno analgezijo.
Respiratory depression following an overdose may outlast the duration of action of the opioid antagonist. 
Depresija dihanja po prevelikem odmerjanju lahko traja dlje od delovanja opioidnega antagonista.
Concomitant use of analgesics was not allowed after 3 hours in Studies C-2000-007 and CAPSS-320. 
Po 3 urah v študijah C-2000-007 in CAPSS-320
Each new system should be placed on a new skin site. 
Vsak nov sistem je treba namestiti na nov kožni predel.
IONSYS only delivers the medicine when you activate it, so you control how much medicine you receive. 
Sistem IONSYS dovaja zdravilo samo, kadar ga sprožite, tako da lahko nadzorujete, koliko zdravila prejmete.
Error message/feedback 
Sporočilo o napaki/povratna informacija
2 years Use immediately after opening. 
Uporabite takoj po odprtju.
In Study CAPSS-319, half the patients in each group received rofecoxib perioperatively and in Study FEN-PPA-401 patients were allowed non-opioid analgesics throughout the study period. 
V študiji CAPSS-319 je pol bolnikov v vsaki skupini perioperativno prejelo rofekoksib in v študiji FEN-PPA-401 so bili v celotnem obdobju študije dovoljeni neopioidni analgetiki.
• tightness/tension in muscles, muscle pain 
• zategovanje/napetost v mišicah, bolečine v mišicah
• you are taking muscle relaxants (prescribed for back pain), or if you are undergoing general 
• jemljete mišične relaksante (predpisane za bolečine v hrbtu) ali če boste potrebovali splošno anestezijo;
In such patients, opioids may decrease respiratory drive and increase airway resistance. 
Pri takšnih bolnikih lahko opioidi zmanjšajo frekvenco dihanja in povečajo upor v dihalnih poteh.
Fentanyl should not be used in patients who may be particularly susceptible to the intracranial effects of CO2 retention, such as those with evidence of increased intracranial pressure, impaired consciousness, or coma. 
Fentanil se ne sme uporabljati pri bolnikih, ki so lahko še posebno občutljivi za intrakranialne učinke zadrževanja CO2, npr. tistih z znaki zvišanega intrakranialnega tlaka, motnjami zavesti ali pri bolnikih v komi.
• Do not touch the sticky side of IONSYS. 
• Ne dotikajte se lepilnega dela sistema IONSYS.
• Align the matching shapes of the controller and the drug unit and firmly press the two parts together at both ends. 
• Poravnajte ujemajoča se dela upravljalnika in zdravilne enote ter trdno pritisnite oba dela skupaj na obeh koncih.
Hypoventilation, hypotension, and profound sedation or coma may occur. 
Nastopijo lahko hipoventilacija, hipotenzija in globoka sedacija ali koma.
Only you know how much pain you are having, and only you should operate IONSYS to start a dose of medicine. 
Samo vi veste, kako močne bolečine imate, in samo vi smete sprožiti sistem IONSYS za odmerjanje zdravila.
The efficacy and safety of IONSYS for treatment of acute, moderate to severe postoperative pain was evaluated in seven controlled studies in 1763 IONSYS patients: three placebo-controlled studies and four active-controlled studies. 
Učinkovitost in varnost zdravila IONSYS pri zdravljenju akutnih, zmernih do hudih pooperativnih bolečin so ocenili v sedmih nadzorovanih študijah pri 1763 bolnikih: treh s placebom nadzorovanih študijah in štirih z zdravilno učinkovino nadzorovanih študijah.
• Remove and discard the clear plastic liner covering the adhesive. 
• Odstranite in zavrzite prozorno plastično folijo, ki prekriva lepilo.
The digital display will show the number of doses that have been 
Digitalni prikazovalnik bo prikazal število dovedenih odmerkov.
- Do not let the IONSYS system get wet because it could stop working or fall off. 
- Sistem IONSYS se ne sme zmočiti, ker bi lahko prenehal delovati ali odpadel.
Additional analyses suggest that the surgical procedure type did not influence the trends in efficacy endpoints and the efficacy of IONSYS was similar across the range of body mass indices studied (< 25 to > 40 kg/m2 
Dodatne analize so pokazale, da vrsta kirurškega postopka ni vplivala na trende opazovanih dogodkov učinkovitosti, in učinkovitost sistema IONSYS je bila podobna v celotnem preiskovanem razponu indeksov telesne mase (od < 25 do ≥ 40 kg/m2 ITM).
If you do use more IONSYS than you should then you may experience shortness of breath, difficulty breathing, rapid and shallow breathing, or feeling faint. 
Če uporabite več zdravila IONSYS, kot bi smeli, se lahko pojavijo zasoplost, težave z dihanjem, hitro in plitvo dihanje ali občutek omedlevice.
• you have a severe or persistent lung disease, or any breathing problems 
• če imate hudo ali dolgotrajno pljučno bolezen ali kakršne koli težave z dihanjem;
Another published article of 52 elderly Japanese post-operative patients receiving continuous intravenous (IV) fentanyl infusion (0.5-1.5 µg/kg/h) showed increased fentanyl exposure in the CYP3A5*3 group (3*/3*) than in the 1* carrier group. 
Drug objavljen članek o 52 starejših japonskih bolnikih, ki so po operaciji prejemali neprekinjeno intravensko (IV) infuzijo fentanila (0,5-1,5 µg/kg/h), razkriva povečano izpostavljenost fentanilu v skupini CYP3A5*3 (3*/3*) v primerjavi s skupino 1*.
As shown below, the primary endpoint, proportion of patients reporting “Good or Excellent” ratings for the two methods of pain relief in all four studies demonstrated equivalence, with each 95% confidence interval contained within the prespecified ± 10% equivalence boundaries. 
Kot je prikazano v nadaljevanju, je primarni opazovani dogodek, delež bolnikov, ki je ocenil obe metodi lajšanja bolečine kot »dobri ali odlični« v vseh štirih študijah, izkazal enakovrednost, pri čemer je bil vsak 95-odstotni interval zaupanja vsebovan v vnaprej opredeljenih ±10-odstotnih mejah enakovrednosti.
Hepatic disease may delay elimination. 
Bolezni jeter lahko zapoznijo izločanje.
If system beeps again, then remove and dispose of system, and place a new system on a different skin site. 
Če sistem znova začne piskati, ga odstranite in zavrzite ter namestite nov sistem na drug kožni predel.
• anaemia (low blood count) 
• anemija (majhno število krvnih celic)
The primary endpoint in each placebo-controlled study was the proportion of withdrawals due to inadequate analgesia during the period from 3 to 24-hours after IONSYS application. 
Primarni opazovani dogodek v vsaki s placebom nadzorovani študiji je bil delež umikov zaradi neustrezne analgezije v obdobju od 3 do 24 ur po namestitvi sistema IONSYS.
IONSYS is composed of an electronic controller and a drug unit with two hydrogels. 
Sistem IONSYS je sestavljen iz elektronskega upravljalnika in zdravilne enote z dvema hidrogeloma.
Each IONSYS carton contains 6 systems. 
Vsaka škatla vsebuje 6 sistemov IONSYS.
• you have severe headaches, have had a significant head injury, or have a brain tumour 
• če imate hude glavobole, ste imeli hujšo poškodbo glave ali imate možganski tumor;
There are no clinical data on the effects of fentanyl on fertility. 
Ni kliničnih podatkov o vplivih fentanila na plodnost.
Dose proportionality has been demonstrated from 25 to 60 micrograms per dose. 
Linearnost/nelinearnost Sorazmernost odmerka je bila dokazana za od 25 do 60 mikrogramov na odmerek.
Consequently, the patient may activate IONSYS more frequently to maintain fentanyl blood levels. 
Bolnik bo morda zaradi tega aktiviral sistem IONSYS pogosteje, da ohrani raven fentanila v krvi.
The concomitant use of partial opioid agonists/antagonists (e.g. buprenorphine, nalbuphine, pentazocine) is not recommended. 
Sočasna uporaba delnih opioidnih agonistov/antagonistov (npr. buprenorfina, nalbufina, pentazocina) se ne priporoča.
The assembled IONSYS product measures 47 mm x 75 mm. 
Sestavljen izdelek IONSYS meri 47 mm x 75 mm.
• Checklist for monitoring inadequate product disposal to ensure healthcare professionals understand the dangers of inappropriate handling and accidental exposure to the IONSYS 
• Kontrolni seznam za spremljanje neustreznega odstranjevanja sistema zaradi zagotavljanja, da zdravstveni delavci razumejo nevarnosti nenamerne izpostavljenosti sistemu Ionsys in nepravilnega ravnanja z njim.
Due to the well-known potential of abuse of fentanyl, physicians should evaluate patients for a history of drug abuse (see section 4.4). 
Zaradi znane možnosti zlorabe fentanila mora zdravnik oceniti bolnikovo zgodovino zlorabe zdravil in drog (glejte poglavje 4.4).
In patients with chronic obstructive pulmonary disease or patients with conditions pre-disposing them to hypoventilation, more severe adverse reactions may be experienced. 
Pri bolnikih s kronično obstruktivno pljučno boleznijo ali bolnikih z boleznimi, zaradi katerih so dovzetni za hipoventilacijo, se lahko pojavijo hujši neželeni učinki.
The concomitant use of ritonavir or other potent or moderate CYP3A4 inhibitors and IONSYS is not recommended unless the patient is closely monitored. 
Sočasna uporaba ritonavirja ali drugih močnih ali zmernih zaviralcev CYP3A4 z zdravilom IONSYS se ne priporoča, razen ob pozornem spremljanju bolnika.
Supplemental intravenous opioid medication (fentanyl or morphine) was only allowed during the first 3 hours of IONSYS or PCA morphine treatment. 
Dodatno intravensko opioidno zdravilo (fentanil ali morfin) je bilo dovoljeno samo v prvih 3 urah zdravljenja z zdravilom IONSYS ali zdravljenja PCA z morfinom.
If severe or persistent hypotension occurs, hypovolaemia should be considered and the condition should be managed with appropriate parenteral fluid therapy or other interventions as needed, based upon the clinical judgment of the treating health care professional. 
Če se pojavi huda ali persistentna hipotenzija, je treba upoštevati možnost hipovolemije in stanje obvladovati z ustreznim parenteralnim nadomeščanjem tekočine ali drugimi ukrepi, ki so morda potrebni na podlagi klinične presoje lečečega zdravnika.
• The doctor or nurse will put IONSYS on your skin, and take it off or replace it when needed. 
• Zdravnik ali medicinska sestra bosta namestila sistem IONSYS na vašo kožo in ga odstranila ali zamenjala, ko bo potrebno.
Patients with genetic polymorphisms affecting CYP3A4 and CYP3A5 
Bolniki z genetskimi polimorfizmi, ki vplivajo na CYP3A4 in CYP3A5
• Dispose of remainder of the system, containing electronics, according to hospital procedures for battery waste. 
• Preostanek sistema, ki vsebuje elektronske dele, zavrzite po bolnišničnih postopkih za baterijske odpadke.
Each tray is packaged in a folding cardboard carton. 
Vsak podstavek je pakiran v kartonsko škatlo.
Significant respiratory depression may occur with IONSYS; patients must be observed for these effects (see section 4.9). 
Pri uporabi sistema IONSYS se lahko pojavi pomembna depresija dihanja; bolnike je treba opazovati zaradi teh učinkov (glejte poglavje 4.9).
Pharmacokinetic /pharmacodynamic relationship 
Farmakokinetično/farmakodinamično razmerje
See package leaflet for disposal information. 
Glejte navodilo za uporabo za informacije o odstranjevanju.
Detailed information on this medicine is available on the European Medicines Agency (EMA) web site: http://www.ema.europa.eu/. 
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila: http://www.ema.europa.eu/.
The most commonly reported adverse reactions were nausea, vomiting, and application site reactions such as erythema and pruritus. 
Najpogosteje opisani neželeni učinki so navzea, bruhanje in reakcije na mestu aplikacije, kot sta eritem in pruritus.
In this study 28 paediatric patients, 6 to 16 years old, were treated with IONSYS fentanyl 40 micrograms after experiencing inadequate analgesia with IONSYS fentanyl 25 micrograms. 
V tej študiji so 28 pediatričnih bolnikov, starih od 6 do 16 let, zdravili s sistemom IONSYS s 40 mikrogrami fentanila, potem ko je bila analgezija s sistemom IONSYS s 25 mikrogrami fentanila neustrezna.
Around 75% of fentanyl is excreted into the urine, mostly as metabolites, with less than 10% as unchanged active substance. 
Okoli 75 % fentanila se izloči z urinom, večinoma v obliki presnovkov, z manj kot 10-odstotno vsebnostjo nespremenjene zdravilne učinkovine.
Your doctor or nurse will remove the IONSYS system before you leave hospital. 
Zdravnik ali medicinska sestra bosta sistem odstranila, preden boste zapustili bolnišnico.
Prior to launch of IONSYS in each Member State the Marketing Authorisation Holder (MAH) must agree about the content and format of the educational programme, including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority. 
Imetnik dovoljenja za promet z zdravilom se mora pred začetkom trženja zdravila Ionsys dogovoriti s pristojnim nacionalnim organom v vsaki državi članici o vsebini in obliki izobraževalnega programa, vključno s sredstvi obveščanja, načini distribucije in vseh drugih vidikih programa.
• Blinking red light for 15 seconds 
• 15 sekund utripa rdeča lučka
They have high affinity to opioid receptors with relatively low intrinsic activity and therefore partially antagonise the analgesic effect of fentanyl and may induce withdrawal symptoms in opioid dependant patients. 
Te učinkovine imajo visoko afiniteto za opioidne receptorje s sorazmerno majhno intrinzično aktivnostjo, zato delno zavrejo analgetični učinek fentanila in lahko povzročijo odtegnitvene simptome pri bolnikih, odvisnih od opioidov.
This effect could either be due to altered maternal care or a direct effect of fentanyl on the pups. 
Ta učinek bi lahko bil posledica spremenjene oskrbe samice ali neposrednega učinka fentanila na mladiče.
IONSYS is a transdermal system (to be applied on intact skin) that contains a strong analgesic (pain reliever) medicine called fentanyl. 
IONSYS je transdermalni sistem (namenjen namestitvi na nepoškodovano kožo), ki vsebuje močan analgetik (učinkovino za lajšanje bolečin) fentanil.
In summary, the limited size of the overall paediatric exposure is insufficient to guide safe and effective dosing of IONSYS in patients younger than 18 years of age. 
Omejena izpostavljenost pediatrične populacije ne zadošča za varno in učinkovito vodenje odmerjanja zdravila IONSYS pri bolnikih, mlajših od 18 let.
It works by delivering fentanyl through your skin to relieve your pain. 
Deluje tako, da dovaja fentanil skozi kožo in lajša bolečine.
If you have a genetic condition (polymorphism) which affects certain enzymes in your body (CYP3A4 and CYP3A5), inform your doctor. 
Če imate genetsko bolezen (polimorfizem), ki vpliva na nekatere encime v telesu (CYP3A4 in CYP3A5), o tem obvestite svojega zdravnika.
Studies with female rats revealed reduced fertility and enhanced embryo mortality. 
Študije na podganjih samicah so pokazale zmanjšano plodnost in povečano umrljivost zarodkov.
The pharmacokinetic absorption profile will repeat with each application to a new skin site, therefore with each new application, 
Farmakokinetični absorpcijski profil se ponovi pri vsaki aplikaciji na nov kožni predel, zato je pri vsaki novi aplikaciji absorpcija na začetku manjša.
Transdermal system 
transdermalni sistem
The average volume of distribution for fentanyl at steady state is 6 L/kg, the average clearance is 53 L/h. 
Povprečni volumen porazdelitve fentanila v stanju dinamičnega ravnovesja je 6 l/kg in povprečni očistek 53 l/h.
Severe respiratory depression or cystic fibrosis. 
Huda depresija dihanja ali cistična fibroza.
The MAH shall ensure that, following discussions and agreement with the National Competent Authorities in each Member State where IONSYS is launched all healthcare professionals who are expected to prescribe, dispense or administer IONSYS are informed through an information letter on having access to / are provided with the following items: 
Imetnik dovoljenja za promet z zdravilom mora po razpravi in dogovoru s pristojnimi nacionalnimi organi v državah članicah, v katerih se bo zdravilo Ionsys tržilo, zagotoviti, da bodo vsi zdravstveni delavci, pri katerih se pričakujejo predpisovanje, izdajanje ali uporaba zdravila Ionsys, prejeli oziroma bodo z informativnim dopisom obveščeni o dostopu do tega gradiva:
caution is recommended in these patients (see section 4.4). 
Kljub temu je pri teh bolnikih potrebna previdnost (glejte poglavje 4.4).
Hair at the application site should be clipped (not shaved) before system application. 
Pred namestitvijo sistema je treba pristriči (ne obriti) dlake na mestu aplikacije.
Mutagenicity testing in bacteria and in rodents yielded negative results. 
Rezultati testiranja mutagenosti na bakterijah in glodavcih so bili negativni.
Fentanyl may produce bradycardia or hypotension and should, therefore, be administered with caution to patients with bradyarrhythmias or any significant cardiovascular disease. 
Fentanil lahko povzroči bradikardijo ali hipotenzijo, zato se mora uporabljati previdno pri bolnikih z bradiaritmijami ali katero koli pomembno boleznijo srca in ožilja.
As with all fentanyl products, the clearance of fentanyl may be reduced in elderly patients, with a consequent increase in half life. 
Kot pri vseh zdravilih s fentanilom je lahko očistek fentanila pri starejših bolnikih zmanjšan, s posledičnim podaljšanjem razpolovnega časa.
• pain when urinating 
• bolečine pri uriniranju
Literature has shown that the genetic polymorphisms only account for a small amount of variability in concentrations of fentanyl with transdermal administration. 
Iz literature je razvidno, da genetski polimorfizmi predstavljajo le majhno količino variabilnosti v koncentracijah fentanila pri transdermalnem dajanju.
The safety and efficacy of IONSYS in children and adolescents younger than 18 years of age has not been established. 
Pediatrična populacija Varnost in učinkovitost zdravila IONSYS pri otrocih in mladostnikih, starih manj kot 18 let, nista dokazani.
• feeling confused or agitated 
• občutek zmedenosti ali vznemirjenosti
Tell your doctor or nurse if you have taken them within the last 14 days before using IONSYS; 
Obvestite zdravnika ali medicinsko sestro, če ste ta zdravila jemali v zadnjih 14 dneh pred uporabo zdravila
IONSYS should be used with caution in patients with hearing impairment who might not be able to hear the audible signals from the system. 
Okvara sluha Zdravilo IONSYS je treba uporabljati previdno pri bolnikih z okvaro sluha, ki morda ne bodo slišali zvočnih signalov sistema.
What IONSYS looks like and contents of the pack IONSYS is a transdermal system and is made up of an electronic controller (the top housing) and a drug unit (the red bottom housing). 
Izgled zdravila IONSYS in vsebina pakiranja IONSYS je transdermalni sistem, sestavljen iz elektronskega upravljalnika (zgornji del ohišja) in zdravilne enote (rdeči spodnji del ohišja).
• if you are allergic (hypersensitive) to fentanyl, or any of the other ingredients of IONSYS (listed in section 6). 
• če ste alergični na fentanil ali katero koli sestavino zdravila IONSYS (navedeno v poglavju 6);
In these studies, 1313 patients undergoing major surgery were randomized to PCA with intravenous morphine (1 mg morphine bolus, 5 minute lock-out, total of 10 mg/h) delivered by a pump, and 1288 patients were randomized to IONSYS. 
V teh študijah so 1313 bolnikov, ki so prestali večji kirurški poseg, randomizirali v skupino PCA z intravenskim morfinom (1 mg morfina v obliki bolusa, 5-minutna blokada, skupaj 10 mg/h), dovajanim s črpalko, medtem ko so 1288 bolnikov randomizirali na zdravilo IONSYS.
Each IONSYS works for one day (24 hours) and contains 80 doses. 
Vsak sistem IONSYS deluje en dan (24 ur) in vsebuje 80 odmerkov.
Table 2 Active Comparator Trials (n=2569) Evaluable Patients 
Preglednica 2 Ocenljivi bolniki v preskušanjih z aktivnim primerjalnim zdravilom (n = 2569)
Fentanyl is highly lipophilic and is well distributed beyond the vascular system, with a large apparent volume of distribution. 
Fentanil je zelo lipofilen in se dobro porazdeli prek žilnega sistema, z velikim navideznim volumnom porazdelitve.
Study C-2000-007 evaluated patients after undergoing abdominal, thoracic, or orthopedic surgeries; Study CAPSS-319 evaluated patients after undergoing total hip replacement; Study CAPSS-320 assessed IONSYS in patients following abdominal and pelvic surgeries; and Study FEN-PPA-401 assessed patients following major abdominal or orthopedic surgery. 
V študiji C-2000-007 so ocenili bolnike po opravljenih posegih na trebuhu, prsnem košu ali po ortopedskih kirurških posegih; v študiji CAPSS-319 so ocenili bolnike po popolni nadomestitvi kolka; v študiji CAPSS-320 so ocenili zdravilo IONSYS pri bolnikih po kirurških posegih na trebuhu in medenici, v študiji FEN-PPA-401 pa bolnike po večjih posegih na trebuhu ali večjih ortopedskih kirurških posegih.
• you are taking medicines that might make you sleepy such as sleeping tablets, tranquilisers, medicines for anxiety or medicines for allergies (anti-histamines); 
• jemljete zdravila, od katerih lahko postanete zaspani, npr. uspavala, pomirjevala, zdravila za anksioznost ali zdravila za alergije (antihistaminiki);
Depression Thinking abnormal thoughts 
• depresija, nenormalne misli
• The importance of the healthcare professional ensuring that the patient understands how to operate the IONSYS system and that only he/she can press the dosing button during use. 
• Kako pomembno je, da zdravstveni delavec bolnika pouči o delovanju sistema Ionsys in da sme med uporabo samo on pritiskati gumb za odmerjanje.
If it beeps at any other time, or more than once, tell your doctor or nurse immediately. 
Če zapiska ob katerem koli drugem času ali več kot enkrat, o tem nemudoma obvestite zdravnika ali medicinsko sestro.
There are 6 systems per carton. 
V škatli je 6 sistemov.